Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer
Journal of Surgical Oncology. 2012;105(6):577-585.Abstract
Background The aim of this study was to evaluate factors that could possibly affect the outcome of patients failing to achieve pathological complete response (pCR) after anthracycline-containing neoadjuvant chemotherapy (NCT) for breast cancer, and built a prognostic model to predict patients' outcome. Patients and Methods Data from 199 stage II-III breast cancer patients who failed to achieve pCR after NCT were used. Variables at baseline and at surgery (age, menopausal status, tumour size, grade, histotype, node status, vascular invasion, ER, PR, HER-2, Cathepsin D, P53, Topo-IIα, Nm-23, Bcl-2, BAX, MDR, GSTN, PS2, P27, Cyclin D1 and Ki-67) were investigated. Results Tumour marker Ki-67, Cathepsin D status and number of positive lymph nodes at surgery were significant prognostic factors in multivariate analysis for both DFS and OS. According to our prognostic model, the 5-year DFS rates in low, intermediate-low, intermediate-high and high-risk groups were 94%, 65%, 43% and 28%, respectively (log-rank test P < 0.001). The 5-year OS rates in these four groups were 94%, 84%, 66% and 34%, respectively (log-rank test P < 0.001). Conclusion Our prognostic model could easily discriminate patients with different risks of experiencing an event or death, which could allow physicians to tailor treatment strategies specifically and individually. J. Surg. Oncol. 2012; 105:577-585. © 2011 Wiley Periodicals, Inc.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Sheng Chen; Can-Ming Chen; Ke-Da Yu; Ruo-Ji Zhou; Zhi-Ming ShaoAnnals of Surgical Oncology. 2012;19(9):3002-3011.
Rosalinda Alvarado; Min Yi; Huong Le-Petross; Michael Gilcrease; Elizabeth A. Mittendorf; Isabelle Bedrosian; Rosa F. Hwang; Abigail S. Caudle; Gildy V. Babiera; Jeri S. Akins; et al.Annals of Surgical Oncology. 2012;19(10):3177-3184.
Henry M. Kuerer; Lisa A. Newman; Aman U. Buzdar; Kelly K. Hunt; Kapil Dhingra; Thomas A. Buchholz; Susan M. Binkley; Frederick C. Ames; Barry W. Feig; Merrick I. Ross; et al.American Journal of Surgery. 1998;176(6):502-509.
Appears in this Document